Chocolate and Cookie Products Recalled Over Allergen Concerns

Multiple chocolate and cookie products have been recalled across various states due to undeclared allergens, raising concerns during the holiday season. The recalls, announced on December 23, 2023, reflect serious safety issues that could affect consumers with specific allergies.

Details of the Recalls

Gregory’s Foods, Inc., based in Minnesota, is recalling its “Bag Full of Cookies” White Chocolate Macadamia Nut frozen cookie dough. The product, sold in 2-pound 8.5-ounce packages, was found to contain undeclared peanuts, posing a significant risk to those with peanut allergies. The company made this announcement in a statement published by the Food and Drug Administration (FDA).

In a separate recall, Atwater’s, a company located in Maryland, is withdrawing 197 cookie tins from the market. These tins were found to contain undeclared tree nuts, which can trigger severe allergic reactions in sensitive individuals, according to an announcement also issued on December 23 by the FDA.

Additionally, Willy Pete’s Chocolate Company LLC from Connecticut is recalling its Almond Despair chocolate bars. The company has confirmed that these bars contain undeclared tree nuts as well, which were not listed on the packaging. This recall is part of a proactive measure to ensure consumer safety during the festive season.

Consumer Impact and Next Steps

Consumers who have purchased these products are advised to check their homes for the affected items and return them to the point of purchase for a full refund. The recalls underscore the importance of clear labeling on food products, particularly during a time when many people are sharing treats and gifts.

The FDA has emphasized the need for food manufacturers to adhere strictly to allergen labeling requirements. Failure to declare allergens can lead to serious health risks, including life-threatening allergic reactions.

These recalls serve as a reminder for consumers to remain vigilant about food labeling, especially during the busy holiday season when many may be trying new products. As the situation develops, both the FDA and the companies involved are committed to ensuring that consumer safety remains the top priority.